Synthesis and evaluation of anti-acetylcholinesterase activity of 2-(2-(4-(2-oxo-2-phenylethyl)piperazin-1-yl)ethyl)isoindoline-1,3-dione derivatives with potential anti-Alzheimer effects

Iranian Journal of Basic Medical Sciences

Volumn 16, Issue 10, 2013, Pages 1049-1054

  Aliabadi, Ali Reza ^a   Foroumadi, Ali Reza ^b   Mohammadi Farani, Ahmad ^a   Garmsiri Mahvar, Mahdi ^a  

^a KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Acetylcholinesterase; Alzheimer; Phthalimide; Synthesis

Indexed keywords

2 2 [4 [2 (4 FLUOROPHENYL) 2 OXOETHYL]PIPERAZIN 1 YL]ETHYL]ISOINDOLINE 1,3 DIONE; 2 [2 (PIPERAZIN 1 YL)ETHYL]ISOINDOLINE 1,3 DIONE; 2 [2 [4 (2 OXO 2 PHENYLETHYL) PIPERAZIN 1 YL] ETHYL]ISOINDOLINE 1,3 DIONE; 2 [2 [4 [2 (2,4 DICHLOROPHENYL) 2 OXOETHYL]PIPERAZIN 1 YL]ETHYL]ISOINDOLINE 1,3 DIONE; 2 [2 [4 [2 (3 CHLOROPHENYL) 2 OXOETHYL]PIPERAZIN 1 YL]ETHYL]ISOINDOLINE 1,3 DIONE; 2 [2 [4 [2 (NAPHTHALEN 2 YL) 2 OXOETHYL]PIPERAZIN 1 YL]ETHYL]ISOINDOLINE 1,3 DIONE; DONEPEZIL; PHTHALIMIDE DERIVATIVE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYMATIC ASSAY; PATHOPHYSIOLOGY; PHYSICAL CHEMISTRY; THIN LAYER CHROMATOGRAPHY;

EID: 84886288348     PISSN: 20083866     EISSN: 20083874     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Maczurek A, Hager K, Kenklies M, Sharman M, Martins R, Engel J, et al. Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer's disease. Adv Drug Del Rev 2008; 60:1463-1470.
2. Scarpini E, Scheltens P, Feldman H. Treatment of Alzheimer's disease: current status and new perspectives. Lancet Neurol 2003; 2:539-547.
3. Ucar G, Gokhan N, Yesilada A, Bilgin AA. 1-N-Substituted thiocarbamoyl-3-phenyl-5-thienyl-2-pyrazolines: A novel cholinesterase and selective monoamine oxidase B inhibitors f or the treatment of Parkinson's and Alzheimer's diseases. Neurosci Lett 2005; 382:327-331.
4. Vitorović-Todorović MD, Juranić IO, Mandić LM, Drakulic BJ. 4-Aryl-4-oxo-N-phenyl-2-aminylbuty-ramides as acetyl- and butyrylcholinesterase inhibitors. Preparation, anticholinesterase activity, docking study, and 3D structure-activity relationship based on molecular interaction fields. Bioorg Med Chem 2010; 18:1181-1193.
5. Yu L, Cao R, Yi W, Yan Q, Chen C, Ma L, et al. Synthesis of 4-[(diethylamino)methyl]-phenol derivatives as novel cholinesterase inhibitors with selectivity towards butyrylcholinesterase. Bioorg Med Chem Lett 2010; 20:3254-3258.
6. Hassan Khan M. Molecular interactions of cholinesterases inhibitors using in silico methods: current status and future prospects. New Biotechnol 2009; 5:331-346.
7. Weinstock M, Groner E. Rational design of a drug for Alzheimer's disease with cholinesterase inhibitory and neuroprotective activity. Chem Biol Interact 2008; 175:216-221.
8. Zhang J, Zhu D, Sheng R, Wu H, Hu Y, Wang F, et al. BZYX, a novel acetylcholinesterase inhibitor, significantly improved chemicals-induced learning and memory impairments on rodents and protected PC12 cells from apoptosis induced by hydrogen peroxide. Eur J Pharmacol 2009; 613:1-9.
9. Mustazza C, Borioni A, Rosaria Del Giudice M, Gatta F, Ferretti R, et al. Synthesis and cholinesterase activity of phenylcarbamates related to Rivastigmine, a therapeutic agent for Alzheimer's disease. Eur J Med Chem 2002; 37:91-109.
10. Kryger G, Israel S, Sussman JL. Structure of acetylcholinesterase complexed with E2020 (AriceptÒ): implications for the design of new anti-Alzheimer drugs. Structure 1999; 3:297-307.
11. Araújo JQ, Araújo de Brito M, Bôas Hoelz LV, de Alencastro RB, Castro HC, Rodrigues CR, et al. Receptor-dependent (RD) 3D-QSAR approach of a series of benzylpiperidine inhibitors of human acetylcholinesterase (HuAChE). Eur J Med Chem 2011; 46:39-51.
12. Dvir H, Silman I, Harel M, Rosenberry TL, Sussman JL. Acetylcholinesterase: From 3D structure to function. Chem Biol Interact 2010; 187:10-22.
13. Liston DR, Nielsen JA, Villalobos A, Chapin D, Jones SB, Hubbard ST, et al. Pharmacology of selective acetylcholinesterase inhibitors: implications for use in Alzheimer's disease. Eur J Pharmacol 2004; 486:9-17.
14. Nukoolkarn SV, Saen-oon S, Rungrotmongkol T, Hannongbua S, Ingkaninan K, Suwanborirux K. Petrosamine, a potent anticholinesterase pyridoacridine alkaloid from a Thai marine sponge Petrosia n. sp. Bioorg Med Chem 2008; 16:6560-6567.
15. Kapková P, Alptüzün V, Frey P, Erciyasb E, Holzgrabe U. Search for dual function inhibitors for Alzheimer's disease: Synthesis and biological activity of acetylcholinesterase inhibitors of pyridinium-type and their Aβ fibril formation inhibition capacity. Bioorg Med Chem 2006; 14:472-478.
16. Alonso D, Dorronsoro I, Rubio L, Munoz P, García-Palomero E, Del Monte M, et al. Donepezil-tacrine hybrid related derivatives as new dual binding site inhibitors of AChE. Bioorg Med Chem 2005; 13:6588-6597.
17. Mary A, Zafiarisoa Renko D, Guillou C, Thal C. Potent acetylcholinesterase inhibitors: design, synthesis, and structure-activity relationships of bis-interacting ligands in the galanthamine series. Bioorg Med Chem 1998; 6:1835-1850.
18. Zhao Q, Yang G, Mei X, Yuan H, Ning J. Novel acetylcholinesterase inhibitors: Synthesis and structure-activity relationships of phthalimide alkyloxyphenyl N,N-dimethylcarbamate derivatives. Pestic Biochem Phys 2009; 95:131-134.
19. Ragavendran JV, Sriram D, Patel SK, Reddy IV, Bharathwajan N, Stables J. Design and synthesis of anticonvulsants from a combined phthalimide-GABA-anilide and hydrazone pharmacophore. Eur J Med Chem 2007; 42:146-151.
20. Sugimoto H, Iimura Y, Yamanishi Y, Yamatsu K. Synthesis and structure-activity relationships of acetylcholinesterase inhibitors: 1-Benzyl-4-[(5,6-dimethoxy-l-oxoindan-2 yl)methyl]piperidine Hydrochloride and related compounds. J Med Chem 1996; 38:4821-4829.
21. Nadri H, Pirali-Hamedani M, Shekarchi M, Abdollahi M, Sheibani V, Amanlou M, et al. Design, Synthesis and anticholinesterase activity of a novel series of 1-benzyl-4-((6-alkoxy-3-oxobenzofuran-2(3H)-ylidin) methyl) pyridinium derivatives. Bioorg Med Chem 2010; 18:6360-6366.
22. Ellman GL, Courtney KD, Andres V, Feather-Stone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961; 7:88-95.